Skip to content
Clinical Trials – home

Region Joenkoepings Laen

Verifiedinfo

Sweden Lanssjukhuset Ryhov, Sjukhusgatan, 553 05 Jönköping, Sweden

  • 20 trials recruiting
  • Breast cancer · Malignant melanoma · Breast cancer metastatic
  • Adults and children

About Specializations

Region Joenkoepings Laen in Jönköping, Sweden specialises in clinical trials of conditions such as Breast cancer, Malignant melanoma, Breast cancer metastatic, Heart failure with preserved ejection fraction, and other specialisations. This site conducts important research.

Main research areas of the site

Retinopathy of Prematurity Research

The Department of Ophtalmology at Region Joenkoepings Laen is conducting a study that evaluates whether topical dexamethasone eye drops can lower the number of infants who require conventional treatment for retinopathy of prematurity.

  • Preventative eye‑drop therapy for premature infants
  • Reduction of invasive laser or cryotherapy procedures
  • Monitoring safety and visual outcomes

The trial involves a multidisciplinary team of 29 investigators and aims to improve early‑intervention strategies for this vulnerable population.

Renal and Skin Cancer Trials

Researchers at the site are evaluating new immune‑targeted combination therapies for patients with advanced clear cell renal cancer and melanoma, focusing on improving survival outcomes.

  • Comparison of novel combination regimens versus standard care
  • Measurement of progression‑free survival
  • Assessment of overall survival benefits
  • Exploration of adjuvant strategies after surgery

With 29 investigators participating, the program seeks to bring more effective systemic options to patients with these high‑risk cancers.

Bladder Cancer Adjuvant Instillation Study

The clinic is running a comparative trial of gemcitabine versus mitomycin as adjuvant intravesical therapy for non‑muscle invasive bladder cancer at intermediate risk of recurrence.

  • Direct comparison of two instillation agents
  • Evaluation of recurrence‑free survival
  • Focus on patients after transurethral tumor resection
  • Safety and tolerability monitoring

This research supports the goal of reducing bladder cancer recurrence and improving quality of life for patients treated at the Jönköping facility.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Lanssjukhuset Ryhov, Sjukhusgatan553 05 JönköpingSweden
Recruiting now
20 trials
Conditions studied
42
Partner status
Verified

More sites in JönköpingSweden

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

41 clinical trials

Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Selatogrel
  • Sponsor:Viatris Innovation GmbH
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:Merck Sharp & Dohme LLC
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Elranatamab
  • Sponsor:Vaestra Goetalandsregionen
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Prednisolone
  • Sponsor:Region Vaesterbotten
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Tamoxifen
  • Sponsor:Karolinska Institutet
Countries:SwedenSweden
  • Participants:18–64 years · Healthy volunteers
  • Substances:Human Papillomavirus Type 11 L1 Protein - Adsorbed - In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
  • Sponsor:Region Stockholm
Countries:SwedenSweden
  • Participants:0–17 years · Healthy volunteers
  • Substances:MEASLES VIRUS EDMONSTON-SCHWARZ STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS
  • Sponsor:Vaestra Goetalandsregionen
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Bleomycin
  • Sponsor:St. Olavs Hospital HF
Registered drug
Countries:SwedenSweden
  • Participants:0–17 years
  • Substances:Verapamil
  • Sponsor:Linkopings Universitet
Registered drug
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Buprenorphine
  • Sponsor:Linkopings Universitet
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Temozolomide
  • Sponsor:Region Oestergoetland
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.